Expertise in
1
conditions

Salih Z. Guclu

Gazi, TR 
Expertise in
1
conditions
Gazi, TR 

Overview

Salih Guclu practices practicing medicine in Gazi, Turkey.

Mr. Guclu is highly rated in 1 condition, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Vaginal Cancer, Lung Cancer, Adenomyosis, and Hysterectomy.

He is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Gazi, Turkey
Other Locations
Dr Suat Seren Göğüs Hastalıkları Ve Cerrahisi Eğitim Ve Araştırma Hastanesi, Egitim, Turkey
Izmir, Turkey
Dr. Suat Seren Göğüs Hastalıkları Ve Cerrahisi Eğitim Ve Araştırma Hastanesi, 331 P1 Blok 2.kat, Konak, Turkey
Yenisehir, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3

19 Total Publications

Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study.
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 26, 2021

Frequently Asked Questions about Salih Z. Guclu

Is Salih Z. Guclu a top-rated expert for Squamous Cell Lung Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Salih Z. Guclu is classified as an Elite expert for Squamous Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Salih Z. Guclu participate in research or clinical trials?

Yes. Salih Z. Guclu has published 19 articles and abstracts on conditions like Squamous Cell Lung Carcinoma. You can view a list of Salih Z. Guclu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guclu's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile